Table 2 90 birds divided into three groups (A, B and C) were used to test protective efficacy of vaccine. A4, B4 and C4 were kept to collect serum for antibody detecting without challenging. All groups were kept in different SPF animal isolator
From: Preparation and evaluation of goose reovirus inactivated vaccine
Group | Immunisation dose (intramuscularly) | Challenge at (days post immunisation) | |
|---|---|---|---|
A | A1 | 0.2 ml vaccine | 7 |
A2 | 0.2 ml vaccine | 12 | |
A3 | 0.2 ml vaccine | 27 | |
A4 | 0.2 ml vaccine | none | |
B | B1 | 0.5 ml vaccine | 7 |
B2 | 0.5 ml vaccine | 12 | |
B3 | 0.5 ml vaccine | 27 | |
B4 | 0.5 ml vaccine | none | |
C | C1 | 0.5 ml PBS | 7 |
C2 | 0.5 ml PBS | 12 | |
C3 | 0.5 ml PBS | 27 | |
C4 | 0.5 ml PBS | none | |